drugset / Trial / NCT00626613

The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)

NCT00626613 ↗

NaSingle-groupDouble-blind

Summary

To evaluate the relationship between Risperidone Treatment, Treatment Discontinuation Rate, and Quality of Life of patients with Alzheimer's Disease and BPSD.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 2 ml Oral
Background Galantamine Small molecule 8 mg —

Indications